miR-187/PDLIM1 Gets Involved in Gastric Cancer Progression and Cisplatin Sensitivity of Cisplatin by Mediating the Hippo-YAP Signaling Pathway

Table 2

The correlation between PDLIM1 expression and clinical characteristics in the tissue specimens of GC patients.

Characteristics	Patients	Expression of PDLIM1		value
		High-PDLIM1	Low-PDLIM1
Total	45	23	22
Age (years)				0.661
<63	21	10	11
≥ 63	24	13	11
Gender				0.668
Male	26	14	12
Female	19	9	10
Tumor location				0.837
Bottom	20	10	10
Body	12	7	5
Gastric antrum	13	6	7
Diameter				0.023
< 3 cm	25	9	16
≥ 3 cm	20	14	6
Clinical stage				0.005
Early	24	17	7
Middle and late	21	6	15
Distant metastasis				0.025
Without	22	15	7
With	23	8	15
Vascular invasion				0.023
Yes	25	9	16
No	20	14	6